Are Trans India House Impex Ltd latest results good or bad?

1 hour ago
share
Share Via
Trans India House Impex Ltd's latest results are positive, showing a net profit of ₹1.72 crores and a revenue increase of 148.61%, but ongoing challenges like low return on capital and high debt raise concerns about the sustainability of this growth.
Trans India House Impex Ltd's latest financial results for the quarter ending March 2026 indicate a notable shift in performance metrics. The company reported a net profit of ₹1.72 crores, reflecting a substantial year-on-year growth of 551.85%, compared to a loss in the same quarter last year. Revenue also saw a significant increase, reaching ₹25.58 crores, which translates to a year-on-year growth of 148.61%. This marks a remarkable recovery from previous quarters, where revenue fluctuations were pronounced.
The operating margin improved to 10.24%, the highest in seven quarters, driven by an operating profit of ₹2.62 crores. This improvement in profitability is noteworthy, especially considering the company's historical volatility in earnings. However, the revenue growth has been characterized by extreme variability, with sequential changes ranging from significant declines to sharp increases, suggesting reliance on a project-based revenue model rather than stable recurring income. Despite these positive quarterly results, the company faces ongoing challenges. The average return on capital employed remains low at 1.54%, indicating operational inefficiencies. Additionally, the company has a high debt-to-EBITDA ratio of 9.08, raising concerns about financial stability and flexibility. The shareholding dynamics reflect a reduction in promoter confidence, with a significant decrease in promoter holdings over the past year, and institutional investor participation remains minimal. Overall, while Trans India House Impex Ltd has demonstrated a strong performance in the latest quarter, the underlying operational challenges and structural weaknesses raise questions about the sustainability of this growth. The company saw an adjustment in its evaluation, reflecting the complexities of its financial health amidst a backdrop of volatility and high leverage.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News